U.S. President Trump’s Immigration Ban Could Inhibit International Research, Prevention Work On Neglected Diseases, Experts Say

Nature: Trump immigration ban upends international work on disease
“Diseases don’t respect borders, laws or walls. And efforts to combat them rely on networks of scientists to detect outbreaks early, understand how the diseases operate, and then intervene. Researchers say that President Donald Trump’s travel ban challenges that process, putting the United States at risk. The policy, enacted on 27 January, bars refugees from entering the country for 120 days, except those from Syria, who are banned indefinitely. Citizens of Iran, Iraq, Libya, Somalia, Sudan, Syria, and Yemen are banned for 90 days. On 1 February, the White House said that the order did not apply to people from those countries who hold U.S. permanent-resident visas, or green cards. Still, ‘the ban could hamper our ability to learn about the epidemiology of neglected diseases emerging out of conflict zones,’ says infectious disease expert Peter Hotez at Baylor College of Medicine in Houston, Texas…” (Maxmen, 2/1).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.